ISSN: 2248-3942

Due to the large number of submitted articles, we have already selected papers to be published during the year 2020 (see the list). To avoid submission of inappropriate articles or delays in publication, the submission process must begin with an e-mail to the editorial office, as described below.

  • The first step in the submission process is represented by sending abstract of the article by e-mail to: Abstract will be read by members of the editorial team, who will inform if you can pass to the second step. It is not recommended to skip this step, as this means that you avoid the preliminary editorial evaluation. The purpose of this evaluation is to determine if your article is appropriate for the journal scope and format, and that your article is not similar to other (already accepted or published) articles.
  • The second step is represented by submission of the full text of article through the ScholarOne submission system. If you have not completed the first step (sending abstract to you will be redirected to it, which means delay in publication.
  • The third step is the reviewing process. After this stage, the corresponding author will receive a message including the final editorial decision (article has been accepted or rejected).

For accepted articles, publication will be processed only after paying a 200 Euro fee per article (for full open access). See here the payment details.

Finally, accepted articles will be published starting with 2021.

Rom Biotechnol Lett.

DOI: 10.25083/rbl
ISSN: 1224-5984 (Print)
ISSN: 2248-3942 (Electronic)
is currently indexed in: see more